Metilfenidato y modafinilo: Justicia igualitaria y políticas de acceso al mejoramiento cognitivo farmacológico

Daniel Loewe

doi:10.4067/S1726-569X2017000100179

Metilfenidato y modafinilo: Justicia igualitaria y políticas de acceso al mejoramiento cognitivo farmacológico

Daniel Loewe

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

3 Citas (Scopus)

Resumen

The article addresses criteria for access to pharmacological cognitive enhancement technologies, especially modafinil and methylphenidate, to healthy adults. From the perspective of equalitarian justice and taking as point of reference Rawls’ theory of justice it argues in favor of a policy of open market access, but facilitated for the worst-off.

Título traducido de la contribución	Methylphenidate and modafinil: Egalitarian justice and policies of access to pharmacological cognitive enhancement
Idioma original	Español
Páginas (desde-hasta)	179-188
Número de páginas	10
Publicación	Acta Bioethica
Volumen	23
N.º	1
DOI	https://doi.org/10.4067/S1726-569X2017000100179
Estado	Publicada - 2017
Publicado de forma externa	Sí

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

ODS 3: Salud y bienestar

Palabras clave

Cognitive pharmacological enhancement
Egalitarian justice
Equality of opportunities
Methylphenidate
Modafinil

Acceder al documento

10.4067/S1726-569X2017000100179

Citar esto

@article{e1273883d0714cbdb0c9ca5dcf06cf58,

title = "Metilfenidato y modafinilo: Justicia igualitaria y pol{\'i}ticas de acceso al mejoramiento cognitivo farmacol{\'o}gico",

abstract = "The article addresses criteria for access to pharmacological cognitive enhancement technologies, especially modafinil and methylphenidate, to healthy adults. From the perspective of equalitarian justice and taking as point of reference Rawls{\textquoteright} theory of justice it argues in favor of a policy of open market access, but facilitated for the worst-off.",

keywords = "Cognitive pharmacological enhancement, Egalitarian justice, Equality of opportunities, Methylphenidate, Modafinil",

author = "Daniel Loewe",

year = "2017",

doi = "10.4067/S1726-569X2017000100179",

language = "Spanish",

volume = "23",

pages = "179--188",

journal = "Acta Bioethica",

issn = "0717-5906",

publisher = "Universidad de Chile - Centro Interdisciplinario de Estudios en Bioetica",

number = "1",

}

TY - JOUR

T1 - Metilfenidato y modafinilo

T2 - Justicia igualitaria y políticas de acceso al mejoramiento cognitivo farmacológico

AU - Loewe, Daniel

PY - 2017

Y1 - 2017

N2 - The article addresses criteria for access to pharmacological cognitive enhancement technologies, especially modafinil and methylphenidate, to healthy adults. From the perspective of equalitarian justice and taking as point of reference Rawls’ theory of justice it argues in favor of a policy of open market access, but facilitated for the worst-off.

AB - The article addresses criteria for access to pharmacological cognitive enhancement technologies, especially modafinil and methylphenidate, to healthy adults. From the perspective of equalitarian justice and taking as point of reference Rawls’ theory of justice it argues in favor of a policy of open market access, but facilitated for the worst-off.

KW - Cognitive pharmacological enhancement

KW - Egalitarian justice

KW - Equality of opportunities

KW - Methylphenidate

KW - Modafinil

UR - https://www.scopus.com/pages/publications/85026839356

U2 - 10.4067/S1726-569X2017000100179

DO - 10.4067/S1726-569X2017000100179

M3 - Article

AN - SCOPUS:85026839356

SN - 0717-5906

VL - 23

SP - 179

EP - 188

JO - Acta Bioethica

JF - Acta Bioethica

IS - 1

ER -

Metilfenidato y modafinilo: Justicia igualitaria y políticas de acceso al mejoramiento cognitivo farmacológico

Resumen

ODS de las Naciones Unidas

Palabras clave

Acceder al documento

Huella

Citar esto